Coya Therapeutics, Inc. COYA
3.18 USD +0.16 (+5.30%)
As ofNov 18, 2026, 12:38 PM EST
3.01 Day range 3.30
2.72 52-week range 6.62
- YTD
- -45.17%
- 1 year
- -48.38%
News
defenseworld.net Coya Therapeutics (NASDAQ:COYA) vs. Evogene (NASDAQ:EVGN) Head to Head Review Evogene (NASDAQ: EVGN - Get Free Report) and Coya Therapeutics (NASDAQ: COYA - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two…benzinga.com HC Wainwright & Co. Reiterates Buy on Coya Therapeutics, Maintains $18 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 price target.
benzinga.com Coya Therapeutics Q3 EPS $(0.45) Misses $(0.34) Estimate, Sales $234.134K Beat $85.714K Estimate Coya Therapeutics (NASDAQ:COYA) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.34) by 32.35 percent. This is a 246.15 percent decrease over losses…
benzinga.com Coya Therapeutics To Highlight ALS Data In Poster Presentation At 2026 Annual NEALS Meeting; Co. Currently Conducts ALSTARS Trial, Phase 2/3, Study To Evaluate COYA 302 For ALS Treatment ALS (amyotrophic lateral sclerosis) is a life-threatening neurodegenerative disease characterized by a highly variable rate of progression among affected individualsThe Company believes…
